Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004568 · ClinicalTrials.gov registry record
Study of Inherited Neurological Disorders
A clinical trial of Motor Neuron Disease and Muscular Dystrophy, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Recruiting
- Registry status
- 3,500
- Enrollment target
- 2
- Study locations
NCT00004568 is a study of Motor Neuron Disease and Muscular Dystrophy that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 3,500 participants, above the 324-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (980% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT00004568, a study of Motor Neuron Disease and Muscular Dystrophy, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is designed to learn more about the natural history of inherited neurological disorders and the role of heredity in their development. It will examine the genetics, symptoms, disease progression, treatment, and psychological and behavioral impact of diseases in the following categories: hereditary peripheral neuropathies; hereditary myopathies; muscular dystrophies; hereditary motor neuron disorders; mitochondrial myopathies; hereditary neurocognitive disorders; inherited neurological disorders without known diagnosis; and others. Many of these diseases, which affect the brain, spinal cord, muscles, and nerves, are rare and poorly understood. Children and adults of all ages with various inherited neurological disorders may be eligible for this study. Participants will undergo a detailed medical and family history, and a family tree will be drawn. They will also have a physical and neurological examination that may include blood test and urine tests, an EEG (brain wave recordings), psychological tests, and speech and language and rehabilitation evaluations. A blood sample or skin biopsy may be taken for genetic testing. Depending on the individual patient s symptoms, imaging tests such as X-rays, CT or MRI scans and muscle and nerve testing may also be done. Information from this study may provide a better understanding of the genetic underpinnings of these disorders, contributing to improved diagnosis, treatment, and genetic counseling, and perhaps leading to additional studies in these areas.
Conditions Studied
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Other
- University of Mali - Bamako
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2000-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004568
The ClinicalTrials.gov registry entry for NCT00004568 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 324-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (980% higher). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Motor Neuron Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00004568 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT00004568 about?
NCT00004568 is a clinical study titled "Study of Inherited Neurological Disorders". This study is designed to learn more about the natural history of inherited neurological disorders and the role of heredity in their development. It will examine the genetics, symptoms, disease progression, treatment, and psychological and behavioral impact of diseases in the following categories: h...
What is the current status of trial NCT00004568?
This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2000-02-18.
What conditions does trial NCT00004568 study?
This clinical trial studies the following conditions: Motor Neuron Disease, Muscular Dystrophy, Muscular Disease, Peripheral Nervous System Disease.
Who is sponsoring clinical trial NCT00004568?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004568 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Motor Neuron Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
RECRUITING
-
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
RECRUITING
-
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
RECRUITING
-
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RECRUITING
-
Non-invasive BCI-controlled Assistive Devices
RECRUITING · NA
-
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.